Both Epacadostat and TCDD treatment led to activation of the AhR reporter (Supplementary Fig. 5d), upregulation of IDO1 expression (Supplementary Fig. 5e), and the nuclear translocation of AhR in both tumor cells and splenic T cells (Supplementary Fig. 5f–i). This evidence concerns the gene AHR and neoplasm.